FLOVENT INHALERS - AEM INH-ORL 25MCG/AEM
FLOVENT INHALERS - AEM INH-ORL 25MCG/AEM
Discontinued
DIN Number
02213583
Drug Class
Human
Market Date
Nov 27, 1998
Company
HC
GlaxoSmithKline Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02213583
AIG Number0124685002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
R03BA05 FLUTICASONE
Product Specifications
Dosage FormMetered-Dose Aerosol
Route of AdministrationOral
,
Inhalation
AHFS Classification52:08.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
FLUTICASONE PROPIONATEActive
Strength: 25 MCG / ACT
Monograph: FLUTICASONE PROPIONATE